Results 41 to 50 of about 20,954 (250)

Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei

Journal for ImmunoTherapy of Cancer, 2021
Background Pseudomyxoma peritonei (PMP) is a rare, slow-growing abdominal cancer with no efficacious treatment options in non-resectable and recurrent cases. Otherwise, rare activating mutations in the GNAS oncogene are remarkably frequent in PMP and the
K. Flatmark, A. Torgunrud, K. G. Fleten, B. Davidson, H. Juul, N. Mensali, Christin Lund-Andersen, E. Inderberg   +7 more
semanticscholar   +1 more source

Prognostic factors influencing infectious complications after cytoreductive surgery and HIPEC. Results from a tertiary referral center [PDF]

, 2019
Background. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) showed promising results in selected patients. High morbidity restrains its wide application.
Carbonari, Ludovica, Cardi, Maurizio, D'Agostino, Claudia, Fonsi, Giovanni Battista, Francesco Di Marzo,, Francesco, Lefoche, LA TORRE, Giuseppe, Sammartino, Paolo, Sibio, Simone   +8 more
core   +1 more source

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei

Frontiers in Oncology, 2021
Purpose To investigate the expression of carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), CA19-9, CA724, and CA242 in serum and ascites of pseudomyxoma peritonei (PMP) patients and evaluate the predictive value of these elevated biomarkers in ...
Lei Liang, Jingyang Fang, Xuedi Han, X. Zhai, Yan Song, Yiyan Lu, Qian Zhang, R. Ma   +7 more
semanticscholar   +1 more source

Molecular analysis of appendiceal mucinous cystadenoma and rectal adenocarcinoma in a patient with urothelial carcinoma: a case report [PDF]

, 2013
Introduction: In this report, we present the case of a patient affected by appendiceal cystadenoma, a colorectal adenocarcinoma, and a concomitant bladder carcinoma, as well as the results of the molecular study of the most relevant mutational pathways ...
Colombino, Maria, Cossu, Antonio, Paliogiannis, Panagiotis, Palmieri, Giuseppe, Pulighe, Fabio, Scognamillo, Fabrizio, Trignano, Mario   +6 more
core   +1 more source

Novel Perspectives in Pseudomyxoma Peritonei Treatment

Cancers, 2021
Simple Summary Pseudomyxoma Peritonei (PMP) represents a rare entity which greatly benefits from Cytoreductive Surgery (CRS) associated with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
A. Sommariva, M. Tonello, Giulia Rigotto, Nayana Lazzari, P. Pilati, M. L. Calabrò   +5 more
semanticscholar   +1 more source

Rare primary peritoneal mucinous adenocarcinoma in a 69‐year‐old man

Clinical Case Reports, 2021
Primary peritoneal mucinous adenocarcinoma is rare in men. The low‐grade tumor consisted of mucin‐producing columnar cells with minimal nuclear atypia. Relationship to pseudomyxoma peritonei and disseminated peritoneal adenomucinosis is discussed.
Fumiko Satoh, Yutaka Tsutusmi
doaj   +1 more source

Incidental Diagnosis of Pseudomyxoma Peritonei: A Case Report

Cureus, 2022
Pseudomyxoma peritonei (PMP) is a rare clinical condition characterized by disseminating gelatinous ascites within the peritoneal cavity with mucinous implants on peritoneal surfaces.
G. Sarpietro, Marco Iraci Sareri, G. Bonanno, M. G. Matarazzo, A. Cianci   +4 more
semanticscholar   +1 more source

Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei

American Journal of Clinical Oncology, 2022
Pseudomyxoma peritonei is an infrequent solid tumor in clinical practice. The low morbidity and deficient understanding of this mucus-secreting malignant disease increase the risks of delayed identification or uncontrollable deterioration. In quite a lot
Sui-Hui Ye, Song Zheng
semanticscholar   +1 more source

A case of Pseudomyxoma Peritonei of an unexpected origin

Diagnostic Pathology, 2021
Background Pseudomyxoma peritonei (PMP) is a complex and partially understood disease defined by mucin deposits in the peritoneal cavity, mostly of appendiceal origin caused by the rupture of a mucocele often containing Low or High grade Appendiceal ...
Marie Csanyi-Bastien, France Blanchard, Aude Lamy, Jean-Christophe Sabourin   +3 more
doaj   +1 more source

Rapid recurrence of a ruptured mucinous borderline ovarian tumor harboring K-RAS mutation followed by progression into anaplastic carcinoma with TP53 mutation

Heliyon, 2022
We describe the case of a young patient with a borderline mucinous ovarian tumor that progressed into ipsilateral ovarian anaplastic carcinoma in only 3 months with metastasis to the contralateral ovary and extensive spread in the pelvic and abdominal ...
Yang Yang, Yanxian Guan, Manman Xu, Junxiu Liu   +3 more
doaj   +1 more source